New insider Wilson David claimed ownership of 72,258 shares (SEC Form 3)
3 - Burke & Herbert Financial Services Corp. (0001964333) (Issuer)
- Director Andrews Julie was granted 37,037 shares, increasing direct ownership by 90% to 78,076 units (SEC Form 4)
4 - RxSight, Inc. (0001111485) (Issuer)
- Director Myers Scott Dunseth was granted 57,100 shares, increasing direct ownership by 17% to 395,895 units (SEC Form 4)
4 - Zentalis Pharmaceuticals, Inc. (0001725160) (Issuer)
- President and CEO Koenig Sheldon L. sold $169,070 worth of shares (53,588 units at $3.15), decreasing direct ownership by 2% to 2,119,111 units (SEC Form 4)
4 - Esperion Therapeutics, Inc. (0001434868) (Issuer)
- Chief Financial Officer Halladay Benjamin sold $33,989 worth of shares (10,773 units at $3.15), decreasing direct ownership by 2% to 702,829 units (SEC Form 4)
4 - Esperion Therapeutics, Inc. (0001434868) (Issuer)
- Director Akella Janaki was granted 7,349 shares, increasing direct ownership by 58% to 19,946 units (SEC Form 4)
4 - SLM Corp (0001032033) (Issuer)
- Director Cadoret-Manier Onaiza was granted 26,455 shares, increasing direct ownership by 17% to 178,156 units (SEC Form 4)
4 - ARDELYX, INC. (0001437402) (Issuer)
- SEC Form 4 filed by Director De Vre Raymond
4 - CODEXIS, INC. (0001200375) (Issuer)
- Director Moon Youngme E was granted 509 shares, increasing direct ownership by 11% to 5,052 units (SEC Form 4)
4 - Mastercard Inc (0001141391) (Issuer)
- SEC Form 4 filed by Director Convis Gary L
4 - SYPRIS SOLUTIONS INC (0000864240) (Issuer)
- Director Morris Rhonda J was granted 2,366 shares, increasing direct ownership by 56% to 6,554 units (SEC Form 4)
4 - Workday, Inc. (0001327811) (Issuer)
- Chief Operating Officer Champoux Jennifer exercised 2,176 shares at a strike of $3.98 and sold $41,344 worth of shares (2,176 units at $19.00) as part of a pre-agreed trading plan (SEC Form 4)
4 - Monte Rosa Therapeutics, Inc. (0001826457) (Issuer)
- Director Dawson Garnet Linn converted options into 250 shares, increasing direct ownership by 1% to 21,500 units (SEC Form 4)
4 - U.S. GoldMining Inc. (0001947244) (Issuer)
- Director Bukacheva Aleksandra converted options into 250 shares, increasing direct ownership by 11% to 2,500 units (SEC Form 4)
4 - U.S. GoldMining Inc. (0001947244) (Issuer)
- SEC Form 3 filed by new insider Baltera Robert Jr.
3 - PALISADE BIO, INC. (0001357459) (Issuer)
- Director Schmidt Laura converted options into 250 shares, increasing direct ownership by 15% to 1,883 units (SEC Form 4)
4 - U.S. GoldMining Inc. (0001947244) (Issuer)
- Chief Executive Officer Smith Timothy Robert converted options into 625 shares, increasing direct ownership by 1% to 57,250 units (SEC Form 4)
4 - U.S. GoldMining Inc. (0001947244) (Issuer)
- Chief Financial Officer Wong Tyler Michael converted options into 250 shares, increasing direct ownership by 20% to 1,500 units (SEC Form 4)
4 - U.S. GoldMining Inc. (0001947244) (Issuer)
- Director Wade Lisa Jean converted options into 250 shares, increasing direct ownership by 20% to 1,500 units (SEC Form 4)
4 - U.S. GoldMining Inc. (0001947244) (Issuer)
- Director Still Alastair Charles converted options into 750 shares, increasing direct ownership by 0.63% to 119,700 units (SEC Form 4)
4 - U.S. GoldMining Inc. (0001947244) (Issuer)